Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success Through Patient Affordability
Express News | Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (Hpv), Advancing Tvgn 920
Express News | Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI Into Preclinical Processes, Accelerating Drug Development and Reducing Costs
Express News | Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
Express News | Tevogen Bio to Provide Timelines Associated With Recently Announced Revenue Forecast and Updates on Operational Readiness This Week
Express News | Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
thanks
Moomoo Buddy : Dear client, the strike price is 11.50USD, for more details you can send the email to us corporateactions@sg.moomoo.com，thank you.